Podcast
Saving Money on Insulin - Frankly Speaking EP 124Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Richard Onorato
When patients with T2DM have difficulty controlling their glucose with standard approaches, or are newly diagnosed but severely hyperglycemic, insulin is commonly used to help control their metabolism. Using long acting, once a day agents is a standard of care but in the last 15 years, the costs of insulin has skyrocketed. During this episode we will review a study examining the effects of using Neutral Protamine Hagedorn Insulin (NPH) rather than once a day insulin on A1c control and risk for hypoglycemia and discuss their findings, which suggest NPH can be used with equivalent glycemic control and with no additional risk.
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 6/10/2019
Expiration Date: 6/10/2020
Topics
Learning Objectives
- Understand the basics of long-acting insulin in care of T2DM
- Appreciate the need to reconsider use of long-acting insulins
- Learn how to switch a much less expensive insulin option with similar outcomes
Faculty Disclosures
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable